Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3129-3131

  Zeimet, Alain G ^a   Offner, Felix A ^b   Marth, Christian ^a   Heim, Kurt ^a   Feichtinger, Hans ^b   Daxenbichler, Günter ^a   Dapunt, Otto ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

CA 125; Interferon; Interleukin 1; Mesothelial cells; Ovarian cancer; Tumor necrosis factor

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN;

ANTIGEN EXPRESSION; ASCITES FLUID; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MESOTHELIUM CELL; MONOLAYER CULTURE; OVARY CANCER; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN SECRETION;

CA-125 ANTIGEN; CELLS, CULTURED; CYTOKINES; EPITHELIUM; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; OVARIAN NEOPLASMS; PERITONEAL CAVITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030820284     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Di-Xia C, Schwartz P, Xinguo L, Zhan Y: Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol 72: 23-27, 1988.
2. Ruibal A, Encabo G, Martinez-Miralles E, Murcia C, Capdevila JA, Salgado A, Martinez-Vasquez JM: CA 125 seric levels in non malignant pathologies. Bull Cancer 71: 145-148, 1984.
3. Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB: Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol 79: 98-104, 1983.
4. Zeimet AG, Müller-Holzner E, Marth C, Daxenbichler G, Dapunt O: Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil Steril 59: 1028-1035, 1993.
5. Hunter VJ, Weinberg JB, Haney AF, Soper JT, Lavin P, Metsch L, Knapp RC Bast RC: CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer. Gynecol Oncol 36: 161-165, 1990.
6. Jäger W, Kissing A, Cilaci S, Melsheimer R, Lang N: Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases ? Br J Cancer 70: 493-495, 1994.
7. Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klingler P, Herold M, Zwierzina H, Hittmair A, Mikuz G, Abendstein B, Zeimet AG, Marth C: IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 7: 542-547, 1995.
8. Bast RC Klug TL, St. John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309: 883-887, 1983.
9. Diez M, Cerdan FJ, Ortega MD, Torres A, Picardo A, Balibrea JL: Evaluation of serum CA 125 as a tumor marker in non-small cell lung cancer. Cancer 67: 150-154, 1991.